Review



low fat diet control  (PMI Nutrition International LLC)


Bioz Verified Symbol PMI Nutrition International LLC is a verified supplier
Bioz Manufacturer Symbol PMI Nutrition International LLC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    PMI Nutrition International LLC low fat diet control
    Low Fat Diet Control, supplied by PMI Nutrition International LLC, used in various techniques. Bioz Stars score: 99/100, based on 2493 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/low fat diet control/product/PMI Nutrition International LLC
    Average 99 stars, based on 2493 article reviews
    low fat diet control - by Bioz Stars, 2026-03
    99/100 stars

    Images



    Similar Products

    99
    PMI Nutrition International LLC low fat diet control
    Low Fat Diet Control, supplied by PMI Nutrition International LLC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/low fat diet control/product/PMI Nutrition International LLC
    Average 99 stars, based on 1 article reviews
    low fat diet control - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    94
    PMI Nutrition International LLC high age diet intake
    High Age Diet Intake, supplied by PMI Nutrition International LLC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/high age diet intake/product/PMI Nutrition International LLC
    Average 94 stars, based on 1 article reviews
    high age diet intake - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    99
    Inotiv envigo diets control diet
    a , The AZD1656 treatment protocol. Mice were fed nutritionally standardized and matched Teklad Standard Base <t>Diet</t> <t>(Envigo),</t> with AZD1656 added to the diet used for the db/db treatment group (30 mg kg −1 body weight). b , In vivo echocardiography assessment of diastolic dysfunction: isovolumic relaxation time (IVRT) <t>(control</t> versus db/db P = 0.0001; control versus AZD P = 0.0002; db/db versus AZD P = 0.0015), mitral valve deceleration (MV decel) (control versus db/db P < 0.0001; control versus AZD P < 0.0036; db/db versus AZD P = 0.0397), myocardial performance index (MPI) (control versus db/db P = 0.0007; control versus AZD P = 0.811; db/db versus AZD P = 0.0521), mitral valve early versus late ratio (E/A) (control versus db/db P = 0.0003 by one-way ANOVA, AZD versus control P = 0.185 and AZD versus db/db P = 0.036 by Fischer’s exact test). The approach to statistical analysis for E/A is described in the . Control n = 17, db/db n = 17, AZD n = 14. c , Representative Langendorff perfused heart. d , Langendorff perfused heart ex vivo function end diastolic pressure (control n = 9; db/db n = 9; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.0344) by one-way ANOVA. e , Langendorff perfused heart ex vivo function systolic pressure (control n = 9; db/db n = 9; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.0344) by one-way ANOVA. f , Representative TTC stained cardiac cross sections after 20 min of total global ischemia and 2 h reperfusion, used for quantification of the infarct size. g , Quantification of infarct size after ischemia–reperfusion injury ( db/db , AZD n = 5 per group; control n = 3) by one-way ANOVA (control versus db/db P = 0.0005; control versus AZD P = 0.1372; db/db versus AZD P = 0.005). h , Improved left ventricular developed pressure (LVDP) recovery after ischemia in Langendorff perfused hearts (control n = 5; db/db n = 5; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.034) by one-way ANOVA. n represents biological replicates (individual animals). Data are presented as mean ± s.e.m. NS, non-significant. Created with BioRender.com.
    Envigo Diets Control Diet, supplied by Inotiv, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/envigo diets control diet/product/Inotiv
    Average 99 stars, based on 1 article reviews
    envigo diets control diet - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    94
    Valiant Co Ltd choline replete control diet
    a , The AZD1656 treatment protocol. Mice were fed nutritionally standardized and matched Teklad Standard Base <t>Diet</t> <t>(Envigo),</t> with AZD1656 added to the diet used for the db/db treatment group (30 mg kg −1 body weight). b , In vivo echocardiography assessment of diastolic dysfunction: isovolumic relaxation time (IVRT) <t>(control</t> versus db/db P = 0.0001; control versus AZD P = 0.0002; db/db versus AZD P = 0.0015), mitral valve deceleration (MV decel) (control versus db/db P < 0.0001; control versus AZD P < 0.0036; db/db versus AZD P = 0.0397), myocardial performance index (MPI) (control versus db/db P = 0.0007; control versus AZD P = 0.811; db/db versus AZD P = 0.0521), mitral valve early versus late ratio (E/A) (control versus db/db P = 0.0003 by one-way ANOVA, AZD versus control P = 0.185 and AZD versus db/db P = 0.036 by Fischer’s exact test). The approach to statistical analysis for E/A is described in the . Control n = 17, db/db n = 17, AZD n = 14. c , Representative Langendorff perfused heart. d , Langendorff perfused heart ex vivo function end diastolic pressure (control n = 9; db/db n = 9; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.0344) by one-way ANOVA. e , Langendorff perfused heart ex vivo function systolic pressure (control n = 9; db/db n = 9; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.0344) by one-way ANOVA. f , Representative TTC stained cardiac cross sections after 20 min of total global ischemia and 2 h reperfusion, used for quantification of the infarct size. g , Quantification of infarct size after ischemia–reperfusion injury ( db/db , AZD n = 5 per group; control n = 3) by one-way ANOVA (control versus db/db P = 0.0005; control versus AZD P = 0.1372; db/db versus AZD P = 0.005). h , Improved left ventricular developed pressure (LVDP) recovery after ischemia in Langendorff perfused hearts (control n = 5; db/db n = 5; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.034) by one-way ANOVA. n represents biological replicates (individual animals). Data are presented as mean ± s.e.m. NS, non-significant. Created with BioRender.com.
    Choline Replete Control Diet, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/choline replete control diet/product/Valiant Co Ltd
    Average 94 stars, based on 1 article reviews
    choline replete control diet - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    95
    PMI Nutrition International LLC control mouse chow teklad td 180537
    a , The AZD1656 treatment protocol. Mice were fed nutritionally standardized and matched Teklad Standard Base <t>Diet</t> <t>(Envigo),</t> with AZD1656 added to the diet used for the db/db treatment group (30 mg kg −1 body weight). b , In vivo echocardiography assessment of diastolic dysfunction: isovolumic relaxation time (IVRT) <t>(control</t> versus db/db P = 0.0001; control versus AZD P = 0.0002; db/db versus AZD P = 0.0015), mitral valve deceleration (MV decel) (control versus db/db P < 0.0001; control versus AZD P < 0.0036; db/db versus AZD P = 0.0397), myocardial performance index (MPI) (control versus db/db P = 0.0007; control versus AZD P = 0.811; db/db versus AZD P = 0.0521), mitral valve early versus late ratio (E/A) (control versus db/db P = 0.0003 by one-way ANOVA, AZD versus control P = 0.185 and AZD versus db/db P = 0.036 by Fischer’s exact test). The approach to statistical analysis for E/A is described in the . Control n = 17, db/db n = 17, AZD n = 14. c , Representative Langendorff perfused heart. d , Langendorff perfused heart ex vivo function end diastolic pressure (control n = 9; db/db n = 9; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.0344) by one-way ANOVA. e , Langendorff perfused heart ex vivo function systolic pressure (control n = 9; db/db n = 9; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.0344) by one-way ANOVA. f , Representative TTC stained cardiac cross sections after 20 min of total global ischemia and 2 h reperfusion, used for quantification of the infarct size. g , Quantification of infarct size after ischemia–reperfusion injury ( db/db , AZD n = 5 per group; control n = 3) by one-way ANOVA (control versus db/db P = 0.0005; control versus AZD P = 0.1372; db/db versus AZD P = 0.005). h , Improved left ventricular developed pressure (LVDP) recovery after ischemia in Langendorff perfused hearts (control n = 5; db/db n = 5; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.034) by one-way ANOVA. n represents biological replicates (individual animals). Data are presented as mean ± s.e.m. NS, non-significant. Created with BioRender.com.
    Control Mouse Chow Teklad Td 180537, supplied by PMI Nutrition International LLC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/control mouse chow teklad td 180537/product/PMI Nutrition International LLC
    Average 95 stars, based on 1 article reviews
    control mouse chow teklad td 180537 - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    99
    PMI Nutrition International LLC control diet
    a , The AZD1656 treatment protocol. Mice were fed nutritionally standardized and matched Teklad Standard Base <t>Diet</t> <t>(Envigo),</t> with AZD1656 added to the diet used for the db/db treatment group (30 mg kg −1 body weight). b , In vivo echocardiography assessment of diastolic dysfunction: isovolumic relaxation time (IVRT) <t>(control</t> versus db/db P = 0.0001; control versus AZD P = 0.0002; db/db versus AZD P = 0.0015), mitral valve deceleration (MV decel) (control versus db/db P < 0.0001; control versus AZD P < 0.0036; db/db versus AZD P = 0.0397), myocardial performance index (MPI) (control versus db/db P = 0.0007; control versus AZD P = 0.811; db/db versus AZD P = 0.0521), mitral valve early versus late ratio (E/A) (control versus db/db P = 0.0003 by one-way ANOVA, AZD versus control P = 0.185 and AZD versus db/db P = 0.036 by Fischer’s exact test). The approach to statistical analysis for E/A is described in the . Control n = 17, db/db n = 17, AZD n = 14. c , Representative Langendorff perfused heart. d , Langendorff perfused heart ex vivo function end diastolic pressure (control n = 9; db/db n = 9; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.0344) by one-way ANOVA. e , Langendorff perfused heart ex vivo function systolic pressure (control n = 9; db/db n = 9; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.0344) by one-way ANOVA. f , Representative TTC stained cardiac cross sections after 20 min of total global ischemia and 2 h reperfusion, used for quantification of the infarct size. g , Quantification of infarct size after ischemia–reperfusion injury ( db/db , AZD n = 5 per group; control n = 3) by one-way ANOVA (control versus db/db P = 0.0005; control versus AZD P = 0.1372; db/db versus AZD P = 0.005). h , Improved left ventricular developed pressure (LVDP) recovery after ischemia in Langendorff perfused hearts (control n = 5; db/db n = 5; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.034) by one-way ANOVA. n represents biological replicates (individual animals). Data are presented as mean ± s.e.m. NS, non-significant. Created with BioRender.com.
    Control Diet, supplied by PMI Nutrition International LLC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/control diet/product/PMI Nutrition International LLC
    Average 99 stars, based on 1 article reviews
    control diet - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    PMI Nutrition International LLC control chow diet
    a , The AZD1656 treatment protocol. Mice were fed nutritionally standardized and matched Teklad Standard Base <t>Diet</t> <t>(Envigo),</t> with AZD1656 added to the diet used for the db/db treatment group (30 mg kg −1 body weight). b , In vivo echocardiography assessment of diastolic dysfunction: isovolumic relaxation time (IVRT) <t>(control</t> versus db/db P = 0.0001; control versus AZD P = 0.0002; db/db versus AZD P = 0.0015), mitral valve deceleration (MV decel) (control versus db/db P < 0.0001; control versus AZD P < 0.0036; db/db versus AZD P = 0.0397), myocardial performance index (MPI) (control versus db/db P = 0.0007; control versus AZD P = 0.811; db/db versus AZD P = 0.0521), mitral valve early versus late ratio (E/A) (control versus db/db P = 0.0003 by one-way ANOVA, AZD versus control P = 0.185 and AZD versus db/db P = 0.036 by Fischer’s exact test). The approach to statistical analysis for E/A is described in the . Control n = 17, db/db n = 17, AZD n = 14. c , Representative Langendorff perfused heart. d , Langendorff perfused heart ex vivo function end diastolic pressure (control n = 9; db/db n = 9; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.0344) by one-way ANOVA. e , Langendorff perfused heart ex vivo function systolic pressure (control n = 9; db/db n = 9; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.0344) by one-way ANOVA. f , Representative TTC stained cardiac cross sections after 20 min of total global ischemia and 2 h reperfusion, used for quantification of the infarct size. g , Quantification of infarct size after ischemia–reperfusion injury ( db/db , AZD n = 5 per group; control n = 3) by one-way ANOVA (control versus db/db P = 0.0005; control versus AZD P = 0.1372; db/db versus AZD P = 0.005). h , Improved left ventricular developed pressure (LVDP) recovery after ischemia in Langendorff perfused hearts (control n = 5; db/db n = 5; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.034) by one-way ANOVA. n represents biological replicates (individual animals). Data are presented as mean ± s.e.m. NS, non-significant. Created with BioRender.com.
    Control Chow Diet, supplied by PMI Nutrition International LLC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/control chow diet/product/PMI Nutrition International LLC
    Average 99 stars, based on 1 article reviews
    control chow diet - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    PMI Nutrition International LLC protein energy kcal g control lab diet
    a , The AZD1656 treatment protocol. Mice were fed nutritionally standardized and matched Teklad Standard Base <t>Diet</t> <t>(Envigo),</t> with AZD1656 added to the diet used for the db/db treatment group (30 mg kg −1 body weight). b , In vivo echocardiography assessment of diastolic dysfunction: isovolumic relaxation time (IVRT) <t>(control</t> versus db/db P = 0.0001; control versus AZD P = 0.0002; db/db versus AZD P = 0.0015), mitral valve deceleration (MV decel) (control versus db/db P < 0.0001; control versus AZD P < 0.0036; db/db versus AZD P = 0.0397), myocardial performance index (MPI) (control versus db/db P = 0.0007; control versus AZD P = 0.811; db/db versus AZD P = 0.0521), mitral valve early versus late ratio (E/A) (control versus db/db P = 0.0003 by one-way ANOVA, AZD versus control P = 0.185 and AZD versus db/db P = 0.036 by Fischer’s exact test). The approach to statistical analysis for E/A is described in the . Control n = 17, db/db n = 17, AZD n = 14. c , Representative Langendorff perfused heart. d , Langendorff perfused heart ex vivo function end diastolic pressure (control n = 9; db/db n = 9; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.0344) by one-way ANOVA. e , Langendorff perfused heart ex vivo function systolic pressure (control n = 9; db/db n = 9; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.0344) by one-way ANOVA. f , Representative TTC stained cardiac cross sections after 20 min of total global ischemia and 2 h reperfusion, used for quantification of the infarct size. g , Quantification of infarct size after ischemia–reperfusion injury ( db/db , AZD n = 5 per group; control n = 3) by one-way ANOVA (control versus db/db P = 0.0005; control versus AZD P = 0.1372; db/db versus AZD P = 0.005). h , Improved left ventricular developed pressure (LVDP) recovery after ischemia in Langendorff perfused hearts (control n = 5; db/db n = 5; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.034) by one-way ANOVA. n represents biological replicates (individual animals). Data are presented as mean ± s.e.m. NS, non-significant. Created with BioRender.com.
    Protein Energy Kcal G Control Lab Diet, supplied by PMI Nutrition International LLC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/protein energy kcal g control lab diet/product/PMI Nutrition International LLC
    Average 99 stars, based on 1 article reviews
    protein energy kcal g control lab diet - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    94
    PMI Nutrition International LLC isocaloric control diet
    a , The AZD1656 treatment protocol. Mice were fed nutritionally standardized and matched Teklad Standard Base <t>Diet</t> <t>(Envigo),</t> with AZD1656 added to the diet used for the db/db treatment group (30 mg kg −1 body weight). b , In vivo echocardiography assessment of diastolic dysfunction: isovolumic relaxation time (IVRT) <t>(control</t> versus db/db P = 0.0001; control versus AZD P = 0.0002; db/db versus AZD P = 0.0015), mitral valve deceleration (MV decel) (control versus db/db P < 0.0001; control versus AZD P < 0.0036; db/db versus AZD P = 0.0397), myocardial performance index (MPI) (control versus db/db P = 0.0007; control versus AZD P = 0.811; db/db versus AZD P = 0.0521), mitral valve early versus late ratio (E/A) (control versus db/db P = 0.0003 by one-way ANOVA, AZD versus control P = 0.185 and AZD versus db/db P = 0.036 by Fischer’s exact test). The approach to statistical analysis for E/A is described in the . Control n = 17, db/db n = 17, AZD n = 14. c , Representative Langendorff perfused heart. d , Langendorff perfused heart ex vivo function end diastolic pressure (control n = 9; db/db n = 9; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.0344) by one-way ANOVA. e , Langendorff perfused heart ex vivo function systolic pressure (control n = 9; db/db n = 9; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.0344) by one-way ANOVA. f , Representative TTC stained cardiac cross sections after 20 min of total global ischemia and 2 h reperfusion, used for quantification of the infarct size. g , Quantification of infarct size after ischemia–reperfusion injury ( db/db , AZD n = 5 per group; control n = 3) by one-way ANOVA (control versus db/db P = 0.0005; control versus AZD P = 0.1372; db/db versus AZD P = 0.005). h , Improved left ventricular developed pressure (LVDP) recovery after ischemia in Langendorff perfused hearts (control n = 5; db/db n = 5; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.034) by one-way ANOVA. n represents biological replicates (individual animals). Data are presented as mean ± s.e.m. NS, non-significant. Created with BioRender.com.
    Isocaloric Control Diet, supplied by PMI Nutrition International LLC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/isocaloric control diet/product/PMI Nutrition International LLC
    Average 94 stars, based on 1 article reviews
    isocaloric control diet - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    Image Search Results


    a , The AZD1656 treatment protocol. Mice were fed nutritionally standardized and matched Teklad Standard Base Diet (Envigo), with AZD1656 added to the diet used for the db/db treatment group (30 mg kg −1 body weight). b , In vivo echocardiography assessment of diastolic dysfunction: isovolumic relaxation time (IVRT) (control versus db/db P = 0.0001; control versus AZD P = 0.0002; db/db versus AZD P = 0.0015), mitral valve deceleration (MV decel) (control versus db/db P < 0.0001; control versus AZD P < 0.0036; db/db versus AZD P = 0.0397), myocardial performance index (MPI) (control versus db/db P = 0.0007; control versus AZD P = 0.811; db/db versus AZD P = 0.0521), mitral valve early versus late ratio (E/A) (control versus db/db P = 0.0003 by one-way ANOVA, AZD versus control P = 0.185 and AZD versus db/db P = 0.036 by Fischer’s exact test). The approach to statistical analysis for E/A is described in the . Control n = 17, db/db n = 17, AZD n = 14. c , Representative Langendorff perfused heart. d , Langendorff perfused heart ex vivo function end diastolic pressure (control n = 9; db/db n = 9; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.0344) by one-way ANOVA. e , Langendorff perfused heart ex vivo function systolic pressure (control n = 9; db/db n = 9; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.0344) by one-way ANOVA. f , Representative TTC stained cardiac cross sections after 20 min of total global ischemia and 2 h reperfusion, used for quantification of the infarct size. g , Quantification of infarct size after ischemia–reperfusion injury ( db/db , AZD n = 5 per group; control n = 3) by one-way ANOVA (control versus db/db P = 0.0005; control versus AZD P = 0.1372; db/db versus AZD P = 0.005). h , Improved left ventricular developed pressure (LVDP) recovery after ischemia in Langendorff perfused hearts (control n = 5; db/db n = 5; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.034) by one-way ANOVA. n represents biological replicates (individual animals). Data are presented as mean ± s.e.m. NS, non-significant. Created with BioRender.com.

    Journal: Nature Cardiovascular Research

    Article Title: Targeting immunometabolic pathways with AZD1656 alleviates inflammation and metabolic dysfunction in type 2 diabetic cardiomyopathy

    doi: 10.1038/s44161-025-00769-0

    Figure Lengend Snippet: a , The AZD1656 treatment protocol. Mice were fed nutritionally standardized and matched Teklad Standard Base Diet (Envigo), with AZD1656 added to the diet used for the db/db treatment group (30 mg kg −1 body weight). b , In vivo echocardiography assessment of diastolic dysfunction: isovolumic relaxation time (IVRT) (control versus db/db P = 0.0001; control versus AZD P = 0.0002; db/db versus AZD P = 0.0015), mitral valve deceleration (MV decel) (control versus db/db P < 0.0001; control versus AZD P < 0.0036; db/db versus AZD P = 0.0397), myocardial performance index (MPI) (control versus db/db P = 0.0007; control versus AZD P = 0.811; db/db versus AZD P = 0.0521), mitral valve early versus late ratio (E/A) (control versus db/db P = 0.0003 by one-way ANOVA, AZD versus control P = 0.185 and AZD versus db/db P = 0.036 by Fischer’s exact test). The approach to statistical analysis for E/A is described in the . Control n = 17, db/db n = 17, AZD n = 14. c , Representative Langendorff perfused heart. d , Langendorff perfused heart ex vivo function end diastolic pressure (control n = 9; db/db n = 9; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.0344) by one-way ANOVA. e , Langendorff perfused heart ex vivo function systolic pressure (control n = 9; db/db n = 9; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.0344) by one-way ANOVA. f , Representative TTC stained cardiac cross sections after 20 min of total global ischemia and 2 h reperfusion, used for quantification of the infarct size. g , Quantification of infarct size after ischemia–reperfusion injury ( db/db , AZD n = 5 per group; control n = 3) by one-way ANOVA (control versus db/db P = 0.0005; control versus AZD P = 0.1372; db/db versus AZD P = 0.005). h , Improved left ventricular developed pressure (LVDP) recovery after ischemia in Langendorff perfused hearts (control n = 5; db/db n = 5; AZD n = 6; control versus db/db P = 0.0001; control versus AZD P = 0.0001; db/db versus AZD P = 0.034) by one-way ANOVA. n represents biological replicates (individual animals). Data are presented as mean ± s.e.m. NS, non-significant. Created with BioRender.com.

    Article Snippet: The db/db and lean controls were divided into 3 groups at 13 weeks of age: group 1, lean controls, Envigo diets control diet (2019 Teklad Global 19% Protein Rodent Diet, irradiated, Teklad Custom Diets, Envigo); group 2, db/db , Envigo diets control diet; group 3, db/db , AZD1656 diet (30 mg kg −1 body weight per day, Envigo Specialist Diets; drug dosing based on refs. , ) (Fig. ).

    Techniques: In Vivo, Control, Ex Vivo, Staining